Rankings
▼
Calendar
RMD Q3 2021 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$35B
Q3 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$769M
-0.1% YoY
Gross Profit
$447M
58.2% margin
Operating Income
$223M
29.1% margin
Net Income
-$78M
-10.2% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
-3.9%
Cash Flow
Operating Cash Flow
$196M
Free Cash Flow
$167M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$4.6B
Total Liabilities
$1.9B
Stockholders' Equity
$2.7B
Cash & Equivalents
$231M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$769M
$769M
-0.1%
Gross Profit
$447M
$450M
-0.5%
Operating Income
$223M
$218M
+2.7%
Net Income
-$78M
$163M
-148.1%
Revenue Segments
Devices And Masks
$675M
88%
Software As Service
$94M
12%
Geographic Segments
Us Canada And Latin America
$497M
65%
Combined Europe Asia And Other Markets
$272M
35%
← FY 2021
All Quarters
Q4 2021 →